Pages that link to "Item:Q6055888"
From MaRDI portal
The following pages link to Adaptive enrichment designs with a continuous biomarker (Q6055888):
Displaying 10 items.
- Inference for a two-stage enrichment design (Q2054525) (← links)
- Adjustment for exploratory cut‐off selection in randomized clinical trials with survival endpoint (Q3299056) (← links)
- Estimation of treatment effects in all‐comers randomized clinical trials with a predictive marker (Q3465715) (← links)
- Addressing small sample size bias in multiple‐biomarker trials: Inclusion of biomarker‐negative patients and Firth correction (Q4634690) (← links)
- Discussion on “Adaptive enrichment designs with a continuous biomarker” by Nigel Stallard (Q6055891) (← links)
- Discussion on “Adaptive enrichment designs with a continuous biomarker” by Nigel Stallard (Q6055893) (← links)
- New insights into adaptive enrichment designs (Q6056988) (← links)
- Bayesian adaptive trial design for a continuous biomarker with possibly nonlinear or nonmonotone prognostic or predictive effects (Q6079625) (← links)
- Subgroup analysis and adaptive experiments crave for debiasing (Q6602034) (← links)
- Finding the best subgroup with differential treatment effect with multiple outcomes (Q6615893) (← links)